What Should Corporations Review in a Spac Agreement?

Domaine d’activité :Corporate

A SPAC agreement is the foundational contract governing a merger or business combination between a special purpose acquisition company and an operating company, typically establishing the deal structure, valuation, representations, and post-closing governance.


SPAC agreements operate under federal securities law, state corporate law, and contractual principles that create binding obligations for both parties well before shareholder approval. The agreement's enforceability, termination rights, and indemnification provisions often determine whether disputes resolve through negotiation, arbitration, or litigation. This article covers the core structural elements a corporation should evaluate, common negotiation leverage points, and practical considerations for protecting your interests through deal closure and beyond.

Contents


1. What Are the Essential Components of a Spac Agreement?


A SPAC agreement typically contains representations and warranties from both parties, purchase price adjustments, closing conditions, indemnification provisions, and termination rights that define when either party can walk away.

The merger consideration structure sets the economic deal and may include cash, stock, or a combination, often with earnout provisions tied to future performance. Representations and warranties create contractual liability; a corporation must carefully scope what it represents about financials, contracts, litigation, and regulatory compliance, as these become the basis for indemnification claims post-closing. Closing conditions such as regulatory approvals, third-party consents, and material adverse change clauses can become flashpoints if circumstances shift between signing and closing. Indemnification caps, baskets, and survival periods define the window and dollar limits for post-closing claims, directly affecting your exposure after the transaction closes.



How Do Representations and Warranties Create Liability?


Representations and warranties are contractual statements of fact that, if breached, trigger indemnification obligations or termination rights. A corporation making representations must ensure they are accurate at signing and at closing; an inaccuracy discovered post-closing can result in an indemnification claim reducing the purchase price or requiring a cash payment.

Common representations include the accuracy of financial statements, the absence of undisclosed liabilities, compliance with laws, and the validity of material contracts. Each representation carries a survival period, typically ranging from 12 to 24 months post-closing, during which the SPAC can assert a breach claim. A corporation should work with counsel to draft representations that are accurate, appropriately qualified, and supported by schedules disclosing known exceptions or risks. A representation qualified by a materiality threshold or a specific disclosure schedule narrows the exposure significantly. For example, a representation that the company has no material undisclosed liabilities may expose the corporation to claims if a previously unknown environmental obligation emerges, whereas a representation qualified by a materiality threshold narrows the exposure. Accuracy at signing is critical; if a representation is false when made, the SPAC may have grounds to terminate pre-closing or assert a post-closing indemnification claim.



What Role Do Closing Conditions Play in Deal Risk?


Closing conditions are contractual gates that either party can invoke to defer or terminate the transaction if circumstances change materially between signing and closing. Material adverse change clauses, regulatory approval conditions, and third-party consent requirements are the most common leverage points in SPAC negotiations.

A material adverse change, or MAC, typically permits termination if an event materially harms the target company's business, financial condition, or prospects. MAC clauses often exclude general economic conditions, industry-wide changes, and events known at signing, which narrows the SPAC's termination right but may still leave room for dispute. Regulatory approvals, such as antitrust clearance or industry-specific licenses, often condition closing; delays or unexpected conditions can push closing timelines or create uncertainty about deal viability. Third-party consents, such as customer or supplier approvals, may be required under material contracts; failure to obtain consent can give either party grounds to terminate or renegotiate. A corporation should identify which conditions are within its control, which require SPAC cooperation, and which are external risks.



2. How Should a Corporation Approach Indemnification Negotiations?


Indemnification provisions define post-closing liability for breaches of representations, warranties, and covenants; a corporation negotiates caps, baskets, survival periods, and carve-outs to limit exposure and clarify what claims are covered.

Indemnification caps are dollar thresholds above which the indemnifying party is not liable; a typical structure includes a deductible or basket, often 0.1% to 1% of deal value, below which no claims are paid, a per-claim threshold, and an aggregate cap, often 10% to 20% of deal value. Baskets and caps directly reduce your post-closing liability; negotiating these terms is critical. Survival periods define how long the SPAC can assert claims; representations typically survive 12 to 24 months, though fundamental reps like title, organization, and authority may survive longer. A corporation should push for shorter survival periods on reps that are less material or harder to verify post-closing. Carve-outs exclude certain items from indemnification; for example, a corporation may carve out claims arising from pre-closing litigation known to the SPAC or disclosed on a schedule. A corporation should also clarify whether indemnification is the exclusive remedy or whether the SPAC retains other claims, such as breach of contract; exclusive remedy provisions protect the corporation by capping total exposure.



What Strategies Reduce Post-Closing Indemnification Risk?


Disclosure schedules, materiality qualifiers, and escrow arrangements are practical tools a corporation uses to reduce post-closing indemnification claims and demonstrate good faith at the negotiation table.

Disclosure schedules are detailed lists of exceptions to representations; by disclosing a known issue, a corporation removes it from the scope of the representation and eliminates the SPAC's indemnification right for that issue. Thorough disclosure schedules reduce post-closing disputes significantly. Materiality qualifiers, such as no material contracts have been terminated or no litigation has been initiated except as disclosed, narrow the scope of what constitutes a breach. Materiality thresholds, such as a $100,000 floor for individual contract breaches, further limit exposure. Escrow arrangements, where a portion of the purchase price is held in escrow for a defined period to secure indemnification claims, align incentives; the SPAC has funds available to satisfy claims, reducing the likelihood of aggressive claims for minor breaches. A corporation should also obtain representations and warranties insurance if budget permits; RWI covers certain post-closing breaches, protecting both parties and reducing disputes over claim interpretation. Working with counsel to draft precise, well-supported representations backed by thorough disclosure schedules and, where feasible, RWI coverage, significantly reduces post-closing friction.



3. What Termination Rights and Remedies Should a Corporation Understand?


SPAC agreements typically grant both parties termination rights tied to closing conditions, material breaches, or the passage of time; understanding these rights helps a corporation evaluate walk-away scenarios and litigation posture.

Termination rights often include the right to terminate if closing has not occurred by a specified outside date, if a material adverse change occurs, if the other party materially breaches a representation or covenant and does not cure within a specified period, or if required regulatory approvals are denied. The outside date is a critical deadline; if closing has not occurred by that date and no party has waived it, either party can typically terminate without penalty. Material breach termination rights require the breaching party to receive written notice and a cure period, usually 15 to 30 days, before termination becomes effective. A corporation should ensure it understands which covenants are material and what cure periods apply. Remedies for wrongful termination vary; specific performance is rarely available in SPAC mergers but may be sought in limited circumstances. Damages for breach are more common; a corporation may claim damages for the SPAC's failure to use best efforts to obtain regulatory approval or for a material breach of a covenant.



How Does New York Law Affect Spac Agreement Enforcement?


SPAC agreements typically specify New York law as the governing law and often include New York arbitration or litigation provisions; New York courts apply contract interpretation principles that favor the plain language of the agreement and may limit remedies if the agreement explicitly allocates risk.

New York courts interpret SPAC agreements under general commercial contract principles, looking first to the agreement's plain language. If the agreement includes an arbitration clause, disputes are resolved through arbitration rather than court litigation, which typically offers faster resolution and confidentiality but limits appeal rights. A corporation should ensure it understands the governing law and dispute resolution mechanism before signing; arbitration can be faster and more confidential, but litigation in court may offer broader discovery and appellate review. If a SPAC or target company is located in New York, the agreement will almost certainly be governed by New York law, and a corporation should work with counsel familiar with New York commercial contract practice.



4. What Practical Steps Should a Corporation Take before Signing?


Before executing a SPAC agreement, a corporation should conduct a comprehensive review of representations, validate accuracy, prepare detailed disclosure schedules, and establish clear documentation of known issues or exceptions to minimize post-closing disputes.

Document preservation is critical; a corporation should gather and organize financial records, contracts, litigation files, regulatory correspondence, and other materials that support the accuracy of representations. A corporation should also conduct an internal audit of known liabilities, pending litigation, contract terminations, and regulatory matters; disclosing these proactively in schedules removes them from the scope of representations and prevents post-closing surprises. Materiality thresholds should be negotiated early; a corporation should push for thresholds that exclude minor issues. Third-party consents should be identified and tracked; if a material contract requires consent for the merger, the corporation should begin the consent process early to avoid closing delays. Environmental, tax, and regulatory compliance should be reviewed with specialists to identify potential post-closing liabilities that should be disclosed or carved out. Finally, a corporation should ensure its board of directors approves the agreement and that shareholder approval, if required, is obtained before closing.



How Can a Corporation Prepare for Post-Closing Disputes?


Post-closing dispute preparation begins before signing; a corporation should establish clear communication protocols, preserve evidence of pre-closing accuracy, and maintain detailed records of any post-closing issues the SPAC raises.

Immediately post-closing, a corporation should document any communications from the SPAC regarding potential breaches or indemnification claims. If the SPAC asserts a claim, the corporation should gather evidence supporting the accuracy of the relevant representation at signing. Many SPAC agreements include notice and cooperation provisions; the corporation should comply with these promptly and provide information requested by the SPAC to demonstrate good faith. If a dispute cannot be resolved through negotiation, the corporation should review the agreement's dispute resolution mechanism and, if arbitration is required, prepare for arbitration proceedings. Consider engaging counsel with experience in SPAC disputes early; early counsel involvement can help the corporation evaluate the strength of the SPAC's claims and assess settlement options. A corporation should also track the survival periods of key representations; as a survival period approaches expiration, the SPAC's right to assert new claims terminates, which can shift negotiation leverage in settlement discussions.

Key ComponentPrimary RiskNegotiation Strategy
Representations and WarrantiesPost-closing indemnification claimsNarrow scope, add materiality qualifiers, prepare comprehensive disclosure schedules
Indemnification Caps and BasketsExcessive post-closing liabilityNegotiate lower caps (10–15% of deal value), higher baskets (0.5–1%), shorter survival periods
Material Adverse Change ClauseSPAC termination right or renegotiation pressureDefine MAC narrowly, exclude industry and economic changes, carve out known risks
Third-Party ConsentsClosing delays or deal terminationIdentify consents early, begin process pre-signing, negotiate waiver or alternatives
Exclusive Remedy ProvisionSPAC retains other claims beyond indemnificationNegotiate exclusive remedy language to cap total post-closing exposure

In practice, a corporation that has worked through these components with counsel before signing, negotiated favorable indemnification terms, and maintained meticulous documentation of accuracy at signing and closing is well-positioned to defend against post-closing claims and resolve disputes efficiently. The Aerospace and Defense and Asset Purchase Agreement practice areas offer related guidance on transaction structuring and post-closing obligations. A corporation should also evaluate whether representations and warranties insurance, escrow arrangements, or other risk allocation tools align with the deal structure and budget. Finally, a corporation should ensure it understands the dispute resolution mechanism and, if arbitration is specified, that it is prepared for that process rather than court litigation, as arbitration timelines and procedures differ materially from traditional litigation.


27 May, 2026


Les informations fournies dans cet article sont à titre informatif général uniquement et ne constituent pas un avis juridique. Les résultats antérieurs ne garantissent pas un résultat similaire. La lecture ou l’utilisation du contenu de cet article ne crée pas de relation avocat-client avec notre cabinet. Pour des conseils concernant votre situation spécifique, veuillez consulter un avocat qualifié habilité dans votre juridiction.
Certains contenus informatifs sur ce site web peuvent utiliser des outils de rédaction assistés par la technologie et sont soumis à une révision par un avocat.

Réserver une consultation
Online
Phone